우리나라 건강보험의 위험분담제도가 재정 및 환자접근성에 미친 영향
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이종혁 | - |
dc.contributor.author | 방준석 | - |
dc.date.available | 2021-02-22T08:46:24Z | - |
dc.date.issued | 2018-06 | - |
dc.identifier.issn | 1226-6051 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/4462 | - |
dc.description.abstract | Objective: This study examined the Risk Sharing Agreement (RSA) on pharmaceutical pricing system in Korean national healthinsurance. Through RSA, the insurer was able to maintain the principles in the price listing process while managing the budgeteffectively and improving patient access to new drugs. Despite these positive effects, there are still issues raised by somestakeholders, such as lack of transparency in the listing process and doubts about its effectiveness. Therefore, we investigated theimpacts of RSA on national health insurance financing and patient access to analyze the effects of RSA. Methods: The impact ofRSA was investigated by analyzing the health insurance claims data for 2014∼2016. The degree of improvement in patient accesswas determined by the decreased amount of patients’ payment. Results: Results showed that the financial impact of RSA was notsignificant and patients’ access to the new drug greatly improved. Conclusion: These results show that RSA is a good system forimproving patient access to new drugs without additional expense on insurance. | - |
dc.format.extent | 7 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 한국임상약학회 | - |
dc.title | 우리나라 건강보험의 위험분담제도가 재정 및 환자접근성에 미친 영향 | - |
dc.title.alternative | An Overview of the Risk Sharing Management in Korean National Health Insurance, Focused on the Effect of the Patient Access and Insurance Finance | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.24304/kjcp.2018.28.2.81 | - |
dc.identifier.bibliographicCitation | 한국임상약학회지, v.28, no.2, pp 124 - 130 | - |
dc.citation.title | 한국임상약학회지 | - |
dc.citation.volume | 28 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 124 | - |
dc.citation.endPage | 130 | - |
dc.identifier.kciid | ART002361512 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Risk sharing agreement | - |
dc.subject.keywordAuthor | pharmaceutical pricing | - |
dc.subject.keywordAuthor | patient access | - |
dc.subject.keywordAuthor | insurance finance | - |
dc.subject.keywordAuthor | national health insurance | - |
dc.identifier.url | http://www.ekjcp.org/journal/view.html?doi=10.24304/kjcp.2018.28.2.81 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.